期刊文献+

胃癌根治术全胃切除适应证分析 被引量:2

The indication of total gastrectomy in radical resection for carcinoma of stomach
下载PDF
导出
摘要 目的探讨进展期胃癌根治术中全胃切除合理适应证的影响因素。方法选取哈尔滨医科大学附属肿瘤医院1997年1月-2007年12月期间随访完整的609例胃癌根治术病人,其中全胃切除患者273例,保胃组患者336例,分别定义全胃切除组和保胃组,比较保胃组和全胃切除组的生存差异,分析患者的基本情况、肿瘤部位、分化程度、Borrmann分型、肿块大小、淋巴结转移以及切缘距肿瘤距离因素。结果保胃组生存期明显优于全胃切除组(x。=5.183,P〈0.05)。患者术前Kamofsky、ECOG评分中,保胃组患者明显优于全胃切除组,但Goldman评分全胃切除组较好(P〈0.05)。全胃切除组多为肿块较大、浸润范围广、淋巴结转移多、肿瘤位于胃近端的患者,与保胃组相比差异具有统计学意义(P〈0.01),同时全胃切除与切缘距肿瘤的距离以及分化程度密也具有相关性(P〈O.05)。结论全胃切除并不能延长胃癌患者生存期。肿块较大、肿块呈浸润性生长、肿瘤位于近端、淋巴结转移多是胃癌根治术中行全胃切除的决定因素,肿瘤的切缘距离和分化程度为全胃切除的影响因素,同时患者全胃切除时应考虑其体力、营养状况、心肺功能和疾病严重程度。 Objective To investigate the influencing factors for indication of total gastrectomy in radical resection for carcinoma of stomach. Methods 609 patients from the Tumor Hospital of Harbin Medical University with radical resection for carcinoma of stomach were studied and classified into the total gastrectomy group,which were 273 after total gastrectomy and the partial resection group which were 336 after partial resection. The data were compared between two groups such as tumor position, tumor size, Borrmann, differentiation type, distance from cutting edge to tumor and lymph node metastasis. Results The survival time of the partial resection group was obviously longer than the total gastrectomy group( ~2 = 5. 183 ,P 〈0.05). The preoperative data of partial re- section group was better than total gastrectomy group in Kamofsky and ECOG,while total gastrectomy group better in Goldman( P 〈0.05). There were significant differences of the size of tumor,lymph node metastasis and the ar- eas of infiltration between two groups( P 〈 0.01 ). The total gastrectomy group was associated with the distance from cutting edge to tumor and differentiation type( P 〈 0.05). Conclusion The total gastrectomy can't guarantee a prolonged survival. The determinative factors of total gastrectomy included big lump,lymph node metastasis and a- broad areas of infihration,ect. Nutriture and cardiorespiratory function were important in total gastrectomy.
出处 《实用肿瘤学杂志》 CAS 2013年第4期350-354,共5页 Practical Oncology Journal
关键词 胃癌 根治术 全胃切除 适应证 Gastric cancer Radical resection Total gastrectomy Indication
  • 相关文献

参考文献9

  • 1李敬国,张明军,李娜,洪艳艳,张艳,丁伟,陈振东.两种生活质量评分对甲磺酸伊马替尼治疗胃肠间质瘤患者生活质量评价的可行性[J].山东医药,2011,51(13):33-34. 被引量:17
  • 2Mackay H Buckanovieh R,Hirte H,et al. A phase Ⅱ study single agent of aflibercept( VEGF Trap) in patients with re- current or metastatic gynecologic carcinosarcomas and uter- ine leiomyosarcoma. A trial of the Princess Margaret Hospi- tal, Chicago and California Cancer Phase Ⅱ Consortia [ J ]. Gynecologic oncoiogy ,2012,125 ( 1 ) : 136 - 140.
  • 3Rohwer JM, Kuchel PW, Maher AD. Membrane potential as a dependent variable in ion transport procesis[ J]. Molecu- lar Biology Reports,2002,29 (1/2) :217 - 225.
  • 4Badruddoja M. Total gastrectomy [ J ]. Archives of Surgery, 2009,144(3) :289 - 290.
  • 5Mizutani S, Shioya T, Maejima K, et al. Two successful cura- tive operations using stomach - preserving distal panereatec- tomy with celiac axis resection for the treatment of locally advanced pancreatic body cancer [ J ]. Journal of hepato - biliary - pancreatic surgery, 2009,16 (2) :229 - 233.
  • 6Kim JH, Park SS, Kim J, et al. Surgical outcomes for gastric cancer in the upper third of the stomach[ J]. World Journal of Surgery, 2006,30 (10) : 1870 - 1876.
  • 7Nagase T,Kanai T, Nakagawa M,et al. Analysis of four pa- tients with advanced gastric cancer undergoing gastrectomy after pre- operative combination chemotherapy using do- cetaxel,cisplatin and S - 1 [ J ]. Gan To Kagaku Ryono, 2010,37( 11 ) :2177 - 2179.
  • 8Grau J, Palmero R, Marmol M, et al. Time - related improve- ment of survival in resectable gastric cancer: the role of Jap- anese - style gastreetomy with IY2 lymphadenectomy and ad- juvant chemotherapy [ J ]. World J Surg Oncol, 2006, 11 (4) :53 -61.
  • 9赵国华,王晶,赵宜良.全胃切除术后两种消化道重建术式的比较[J].实用肿瘤学杂志,2009,23(1):4-6. 被引量:1

二级参考文献8

  • 1韩江涛,方宏,黄君,林琦远,孙广运,谢明均.胰十二指肠切除术后消化道原位重建的临床研究[J].中国现代医学杂志,2006,16(11):1731-1733. 被引量:2
  • 2Reddy P,Boci K,Charbonneau C.The epidemiologic,health-related quality of life and economic burden of gastrointestinal stromal tumours[J].Clin Pharm Ther,2007,32(6):557-565.
  • 3Schipper H.Measuring the quality of life of cancer patients:the functional living index cancer:development and validation[J].J Clin Oncol,1984,2(3):472-483.
  • 4Choi H.Response Evaluation of Gastrointestinal Stromal Tumors[J].Oncologist,2008,13(Suppl 2):4-7.
  • 5Jeffrey P,James H,Alice BK,et al.Quality of life among patients with stage Ⅱ and Ⅲ Breast Carcinoma Randomized to Receive High-Dose Chemotherapy with Autologous Bone Marrow support or intermediate-dose chemotherapy[J].Cancer,2005,104(8):1580-1587.
  • 6Conner BL,Cumming C,Nabholtz JM,et al.A longitudinal prospective study of health-related quality of life in breastcancer patients following high-dose chemotherapy with autologous blood stem cell transplantation[J].Bone Marrow Transplantation,2005,36(4):251-259.
  • 7Chawla S,Mohanti BK,Rakshak M,et al.Temporal assessment of quality of life of head and neck cancer patients receiving radical radiotherapy[J].Quality of Life Research,1999,8(5):73-78.
  • 8郝希山,尹健,柳建中,李伟,李强.全胃切除术后五种消化道重建术的比较[J].中华外科杂志,1999,37(8):475-477. 被引量:75

共引文献16

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部